Company intelligence / Profile preview

Anzu Partners

Ownership: Private
Employees: ~50
Development stage: Other

Overview

As an investment firm rather than a drug developer or biotech operator, clinical results are not directly attributable. However, several of its life science investments have achieved FDA approvals and significant clinical milestones via their own programs (e.g., Banyan Biomarkers’ FDA-approved TBI blood test).

Modalities: Small moleculeMonoclonal antibodyGene therapyCRISPR-based therapyDevicemRNA-based drugs
Industry: Investors

Partnerships

Co-investments with LG Technology Ventures and Samsung Venture Investment Corporation in OTI Lumionics.Volvo Cars Tech Fund co-invested in Niron Magnetics.

Beyond the preview

Go deeper on Anzu Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anzu Partners.

Explore the full profile